Hispanic men with low-risk prostate cancer were 21 percent less likely than white men to be placed under active surveillance, the preferred otion for most patients in that situation.
An analysis of nearly 80,000 cases of prostate cancer in the United States from 2010 to 2015 found that the use of active surveillance increased from 13 percent to 33 percent of cases, but that its use also varied widely across the country. The older the men, the more likely they would be treated with active surveillance, but men of Hispanic ethnicity and Medicaid-insured patients were less likely than whites to ge this treatment.
- See “Active Surveillance Use for Prostate Cancer Varies Widely by Region” by Jody A. Charnow on the Renal and Urology News website (January 6, 2021)
- See the full text of the scientific paper “Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US” by Samuel LWashington 3rd et al.
